课题基金 / 基金详情

Radiation-induced p53-independent apoptosis and radiosensitivity in human tumors

Radiation-induced p53-independent apoptosis and radiosensitivity in human tumors
人类肿瘤中放射诱导的不依赖于 p53 的细胞凋亡和放射敏感性
批准号:
15591257
负责人:
HASEGAWA Masatoshi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

HASEGAWA Masatoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.p53-dependent and p53-independent apoptosis induced by radiation, and RBE of carbon ion beams :The aim of this study is to evaluate the relationships between p53 status and radiation-induced apoptosis. Male mice (C57BL/6) and human tumors transplanted to nude mice were irradiated with 200 kV X-rays or carbon ion beams (290MeV/u, 6cm SOBP,NIRS). The incidence of apoptosis of radiosensitive normal tissues and tumor cells having wild-type p53 increased markedly following irradiation (p53-dependent apoptosis), although the incidence of apoptosis of radioresistant tumor cells having mutant-type p53 increased slightly (p53-ihdependent apoptosis). The RBE values of carbon ion beams evaluated by apoptotic cell death were suggested to be more than 4 for a radioresistant tumor having mutant-type p53, about 3 for radiosensitive tumors having wild-type p53, and 1.5-2.1 for radiosensitive normal tissues having wild-type p53 (spermoatogonia of the testis, crypt cells of the small intestine, and neuronal cells of the hippocampus). Furthermore, the RBE values evaluated by the chronic changes of the testis were 1.2-1.6. These results indicated that the heavy ion beams induce more p53-independet apoptosis than X-rays, and the differences in the RBE values between tumors and normal tissues might contribute to a favorable therapeutic ratio in radiotherapy.2.Radiation therapy for radiosensitive human tumors :Treatment results of radiation therapy for radiosensitive human tumors (malignant lymphoma, germinoma, etc.) were analyzed, and the efficacy of radiation was reevaluated.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
粒子線治療とp53
粒子疗法和 p53
DOI: --
发表时间: 2004
期刊: 癌の臨床 50
影响因子: --
作者: [長谷川正俊, 斉藤淳一, 松田真里子, 鈴木義行, 石川仁, 桜井英幸 他, 長谷川正俊]
通讯作者: 長谷川正俊
Ishikawa H.: "Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma."Jpn J Clin Oncol. 33(9). 443-449 (2003)
Ishikawa H.:“原发性中枢神经系统淋巴瘤患者不使用大剂量甲氨蝶呤的放射治疗的可比结果。”Jpn J Clin Oncol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1016/s0360-3016(03)00506-6
发表时间: 2003-09-01
期刊: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
影响因子: 7
作者: [Hasegawa, M, Kojima, M, Nakano, T]
通讯作者: Nakano, T
CT-fluoroscopy guided interstitial brachytherapy with image-based treatment planning for unresectable localy recurrent recta carcinoma
CT 透视引导间质近距离放射治疗和基于图像的治疗计划治疗不可切除的局部复发直肠癌
DOI: --
发表时间: 2004
期刊: Brachytherapy 3
影响因子: --
作者: [長谷川正俊, 斉藤淳一, 松田真里子, 鈴木義行, 石川仁, 桜井英幸 他, 長谷川正俊, 石川仁, 桜井英幸]
通讯作者: 桜井英幸
15
    Effect of heavy ion beam irradiation on radioresistance and differentiation of cancer stem cells in neuronal tumors
    • 批准号:
      23390304
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.56万
    • 财政年份:
      2011
    • 负责人:
      HASEGAWA Masatoshi
    • 依托单位:
    Novel High Frequency-compatible Low-CTE and Low-CHE Heat-resistant Dielectric Materials
    • 批准号:
      21550212
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.0万
    • 财政年份:
      2009
    • 负责人:
      HASEGAWA Masatoshi
    • 依托单位:
    Molecular biological analysis of intratumoral inhomogeneous radiosensitivity
    • 批准号:
      19390324
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2007
    • 负责人:
      HASEGAWA Masatoshi
    • 依托单位:
    p53-independent apoptosis, non-apoptotic programmed cell death, and organelle
    • 批准号:
      17591246
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      HASEGAWA Masatoshi
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: